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Heterocycles are ubiquitous in all kind of compounds of interest, and among all the possible 
synthetic methods of achieving their introduction into an structure, probably the use of a 
metalated analogue is the most direct one. The present review deals with the generation and 
synthetic uses of organometallics formed by metalation of a heterocyclic ring, and can be 
considered as an update of our revision published in 2004 on this topic.1 Therefore, only 
references published from the second quarter of 2003 until the third quarter of 2006 are included, 
and the same restrictions to the literature coverage applies. Thus, only metalated heterocycles 
which have found applicability are considered and transient metalated species forming part of a 
catalytic cycle are excluded. In addition, metalated species where the metal cannot be 
appropriately situated on a carbon but on a more electronegative atom after metalation due to, for 
instance, delocalization will also be excluded. 
As previously,1 the present review is organized by the type of metal and subdivided by the 
type of metalated heterocycle, including methods for their preparation and their synthetic uses. 
 
 
2. Group 1 Metalated Heterocycles 
 
2.1. Lithium heterocycles 
 
Organolithiums keep their leading position as the most frequently employed metalated 
heterocycles, being useful on their own as nucleophiles or as the starting point in the preparation 
of many other metalated systems from less electropositive metals.1-4 Their generation generally 
involves an alkyllithium-promoted halogen-lithium exchange5 or the  simple direct deprotonation 
of the most acidic and stabilizating position of the heterocyclic nucleus with alkylithiums or 
lithium amides. A stabilization which can be produced by an adjacent atom or group in the so-
called “directed ortho-metalation” (DoM). 
 
ISSN 1424-6376 Page 153 ©ARKAT-USA, Inc. 
Issue in Honor of Prof. Alain Krief ARKIVOC 2007 (x) 152-231 
2.1.1. Aromatic five-membered rings 
N-Silylated 2-lithiopyrroles, prepared by bromo-lithium exchange using n-butyllithium, have 
been used recently in an addition reaction to a chiral Weinreb amide in the total synthesis of the 
marine alkaloids (+)-6a and (–)-dragmacidin F.6b N-Methylated 2-lithiopyrrole can be prepared by 
n-butyllithium/N,N,N',N'-tetramethylethylendiamine (TMEDA)-induced lithiation and has been 
employed in a ring-opening of a chiral lactam, as well as N-triisopropylsilyl-3-lithiopyrrole, 
obtained by bromo/lithium exchange, both involved in the preparation of dopaminergic 
tetrahydroindoles.7 Moreover, two methoxycarbonyl groups can be introduced at C-2 and C-5 of 
N-Boc-protected pyrrole in one step by lithiation using lithium tetramethylpiperidide (LiTMP) 
and methyl chloroformate, as in a recent racemic synthesis of the pyrrolizidine alkaloids 
hyacinthacine A1 and 1-epiaustraline.8 N-Substituted indoles have been directly lithiated at C-2 
and used as nucleophiles in addition to ketones,9 as well as in nitration and iodination reactions.10 
The 3-lithiation has been achieved by bromo-lithium exchange and the resulting indolylithium 
employed, for instance, in addition reactions to imines11 or to chromium hexacarbonyl.12 
The 2-lithiation of the furan ring, achieved by direct deprotonation with an alkylithium, and 
the further use of the lithiated species as nucleophile has been frequently used in the last years 
for the introduction of this important moiety. Thus, 2-furanyllithium has been used in alkylation 
reactions13 and addition to carbonyls,14 isoxazolines15 and 1,2,4-triazines,16 as well as in the ring-
opening of lactones.17 2-Lithiated benzofurans have been obtained similarly and used, for 
instance, for an addition reaction to quinones, in a route to pterocarpins.18  
When an halide is present at C-3, the furan ring is directly 2-lithiated using LDA in order to 
avoid a halide-lithium exchange.19 In addition, the tetralithiated tetrakis(2-furyl)methane 
derivative 2 has been generated from the corresponding tetrabrominated derivative 1 after 
bromo-lithium exchange and has been transformed into the tetraformyl derivative 3 by reaction 
with DMF (Scheme 1).20 Moreover, 2,5-dilithiofuran has been obtained and used in double 
































Some substituents at C-3 on the furan ring have shown ortho-directing properties for the 2-
metalation. Thus, 3-aryl and 3-styryl furans have been regioselectively lithiated at C-2, probably 
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by stabilization of the furyl anion by through-space donation of π-density.22 This DoM has also 
been achieved in N-Boc protected 3-aminofuran (4), this group acting as a stabilizer of the 
corresponding 2-furyllithium after preliminary deprotonation through species 5 (Scheme 2). 
Subsequent reaction with electrophiles such as tert-butyl isocyanate gave rise to the 



















3-Lithiofurans, obtained by bromo or iodo/lithium exchange using an alkyllithium, have been 
used, for instance, in addition to carbonyl compounds24 or to carbon dioxide.25 A recent example 
is the 3-lithiation of 3-iodo-2-silyloxyfuran 7  affords metalated species 8, which reacted with 
electrophiles such as benzaldehyde affording the tetronate 9 after mild hydrolysis (Scheme 3).26  
3-Lithiobenzofurans have been generated similarly and used, for example, in the synthesis of 
diarylethene derivatives with photochromic properties.27 There are examples of DoM lithiation at 
the 3-position of a furan or a thiophene ring, as in the 3-cyanation of these systems by lithiation 






















2-Lithiated thiophenes, generated similarly to 2-lithiofurans, have also been employed 
frequently in recent years as nucleophiles, being also the origin of many boron- and tin-
derivatives frequently employed in the preparation of thiophene-derived compound with 
interesting electrooptical properties (see below). The solution structure and chelation properties 
of some of these 2-thienyllithiums have being studied recently by NMR techniques.29 In some 
cases, temperature-dependent behaviors have been observed, as in the LDA-promoted lithiation 
of 2-bromothiophene at –78 ºC which afforded the expected 5-substituted-2-bromothiophene. 
However, the same process at room temperature or 0 ºC gave a 5-alkylated-2,4-
dibromothiophene according to a halogen-transfer-based halogen dance process.30  
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Examples of the use of 2-lithiothiophenes for bromination reactions in the synthesis of 
oligothiophenes,31 or for double addition to 2-thienylcarboxylated compounds in the preparation 
of multicharged methinium compounds can be found.32 There are also examples of the use of 
these heteroaryllithiums in addition reactions to aldehydes for the preparation of core-modified 
porphyrins,33 hetero-calix[4]pyrroles,34 benzo[b]thiophene analogues of pentacene35 or inhibitors 
of type II 17β-hydroxysteroid dehydrogenase,36 as well as in additions to phenanthrolines.37 2-
Alkylation reactions of the corresponding 2-thienyllithiums have been used, for instance, in the 
synthesis of dialkyloligothiophenes for molecular electronic applications.38  
Other examples of the use of 2-lithiothiophenes as nucleophiles can be found in formylation 
reactions,39 achieved even using a 2,5-dilithiated thiophene in a synthesis of 
oligothienylenevinylenes.40 Sulfur can also be used as electrophile, allowing the preparation of 
dithienothiophene41 and annulated oligothiophene derivatives.42 A recent example of the 
introduction of a sulfur atom using 2-thienyllithium reagents is shown in Scheme 4 where the 
reaction of 2-thienyllithium (10) with sulfur, followed by in situ treatment of the formed thiolate 
salt with α-(bromomethyl)acrylic acid gave the sulfanylated thiophene 11, which can be 
converted into dihydrothiopyran 12 upon heating.43 2-Thienyl-derived phosphanes can be 
obtained by treatment of 2-lithiated thiophenes with chlorodiphenylphosphane.44 2-
Thienyllithium can also be used for substitution reactions to dialkyldichlorosilanes driving to 
bis(2-thienyls)silanes, which are precursors to arylsilanediols.45 In addition, benzo[b]thiophene 
can be similarly lithiated at C-2, being used as nucleophile, for instance, in alkylations46 and 
azidations,47 as well as in reactions with Weinreb amides in the synthesis of agonists for the α7 
nicotinic acetylcholine receptor.48 Furthermore, 2-iodoseleniophenes and 2-iodotellurophenes 
have been obtained by direct 2-lithiation of the corresponding chalcogenophenes and subsequent 




















3-Lithiothiophenes have been generated, as usual, by halogen-lithium exchange and used for 
addition reactions to the carbonyl group of 9H-thioxanthen-9-one in the synthesis of modified 
thiophene oligomers,50 to aldehydes in the preparation of ligands for the glucocorticoid 
receptor51 or to sulfur powder in tiolate generation for substituted thiophenes with blue emission 
characteristics.52 However, there are also examples of DoM 3-lithiation performed on 
appropriately substituted thiophenes. Thus, the lithiation of chiral thienyloxazoline 13 generated 
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the 3-thienyllithium species 14, which can be formylated affording thiophenecarbaldehyde 15, a 


























N-Methylpyrazoles, as other N-alkylated analogues, are lithiated at the methyl group when 
treated with alkylithium reagents such as n-butyllithium under kinetic conditions, whereas 
reaction under thermodynamically-controlled conditions affords lithiation at the 5-position, the 
corresponding 5-lithio-1-methylpyrazole showing NMR data in solution consistent with an 
oligomeric structure.54    
N-Substituted imidazoles tend to lithiate with alkyllithiums at C-2 driving to a carbenoid 
species that can be used as a bulky base, as the case of 2-lithio-1-methylimidazole which has 
been used in stereoselective deprotonation of cyclohexene oxides when combined to a chiral 
lithium amide.55 However, 2-lithioimidazoles are employed normally as nucleophiles, for 
instance in addition reactions to aldehydes,56 ketones57 and isocyanates,58 as well as in 
silylation,59 sulfenylation60 and cyclic sulfate ring-opening61 reactions. Benzimidazoles have also 
been lithiated at C-2 using LDA and acylated with esters.62 2-Lithioimidazoles can also be 
generated by treatment of N-methylimidazole (16) with an excess of lithium powder in the 
presence of a catalytic amount of an electron-carrier63 such as isoprene, the lithiated species 17 
being used in addition reactions to carbonyl compounds or imines such as 
benzylidenebenzenamine to give the corresponding 2-substituted imidazole 18 (Scheme 6).64 The 
halogen/lithium exchange has been used for generating 2-lithioimidazoles, an example being the 
n-butyllithium-promoted  2-metalation of a N-protected 2,4,5-triiodinated imidazole, followed by 
addition reaction to 3-indolylcarbaldehydes in the synthesis of anti-inflammatory 
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When the C-2 in N-substituted imidazoles is blocked, the alkyllithium-promoted metalation 
takes place at C-5. Frequently, this metalation-blockage at C-2 is produced by an easily 
removable trialkylsilyl group, the formed 5-lithiated imidazole thus being suitable as 
nucleophile, for instance, in addition reactions to aldehydes66 or ring-opening of lactones.67  
Isoxazoles can not be lithiated at C-5 by deprotonation with alkyllithiums, as the resulting 
anion suffers fragmentation to benzonitrile and ethynolate ion or enaminones, depending on the 
alkyllithium and the substituents present on the ring.68 When the 5-position is blocked, lithiation 
of the ring is possible, as in the case of the treatment of 3,5-disubstituted isoxazole 19 with n-
butyllithium generating 4-isoxazolyllithium species 20, which added to amino acrylate 21 in a 
Michael fashion affording trisubstituted isoxazole 22 in the search of agonists at AMPA 






















Oxazole and benzoxazole can be readily lithiated at the 2-position giving species such as 23, 
although this resulting anion equilibrates by α-elimination/ring-opening with a β-isocyano 
enolate 24, this latter being the dominating form according to NMR.70 Reaction of this 
equilibrating anion are dependent of the electrophile, acyl chlorides such as acetyl chloride 
giving rise to the corresponding isonitrile 25 (Scheme 8).71 This kind of isonitriles are fragant 
and are an interesting alternative to conventionally used isonitriles, which usually have 
hazardous properties and a piercing odor. Concerning 5-bromo-2-phenyloxazole, 5-lithiation and 
further reaction with electrophiles has been achieved through an initial LDA-promoted 4-























The lithiation of isothiazoles and their further reaction with electrophiles has been 
reviewed.73a 2-Lithiothiazole derivatives have been used as nucleophiles, for instance in addition 
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to aldehydes,73b,c the thiazole moiety being used frequently as a formyl anion equivalent.74 This 
heteroaryllithium has been also employed in addition reactions to benzyloxyacetaldoximes.75 In 
addition, 2-lithiobenzothiazoles have been used recently in addition reactions to a 
fuconolactone76 and to an arginine-derived Weinreb amide.77 If the 2-position in thiazoles is 
blocked, the lithiation takes place directly at the 5-position, an example being the synthesis of 5-
thiazole ketones by reaction of n-butyllithium-generated 5-thiazolyllithiums with nitriles.78 The 
5-lithiation has also been achieved in 2-thiazolamines bearing a bromine atom at C-5 through a 
halogen dance process starting from a LDA-promoted 4-lithiation.79 However, when a 4-
lithiation at a C-2-substituted thiazole is intended, the usual route is a halogen-lithium exchange, 
as illustrated in Scheme 9 for the metalation of the brominated thiazole 26 to give the 4-lithiated 
species 27. This intermediate can be formylated using DMF to give thiazolylcarbaldehyde 28, 

























2.1.2. Aromatic six-membered rings 
Pyridines, as other electron-deficient six-membered heteroaromatic rings, are deprotonated using 
lithium amides, instead of alkylithiums, in order to avoid addition to the heteroaromatic ring. The 
use of the combination of n-butyllithium and lithium diethylamino ethoxyde (LiDMAE) has 
shown to be a “superbase” able to efficiently deprotonate the C-2 of pyridines by increasing the 
basicity and nucleophilicity of the alkylithium reagent.81 Thus, recent applications of the use of 
this lithiating combination on 4-picoline and 3,4-lutidine,82 4-(1-pyrrolyl)pyridine,83 (S)-
nicotine,84 anisylpiridines85 and 3-methylthiopyridine were reported.86 A new related “superbase” 
has been developed by combining [(trimethylsilyl]methyl)lithium (TMSCH2Li) and LiDMAE, 
and it has found efficient application for the C-2 lithiation of sensitive chloro- and 
fluoropyridines.87 
The DoM process, combined to the use of a lithium amide base such as LiTMP, can also be 
used for the C-2 lithiation of the pyridine nucleus of 2-(pyridyl)-phenols and anilines.88 This 
DoM methodology has been used in the 2-lithiation of 3-fluoropyridine and further reaction with 
carbon dioxide89 and has also allowed the extensive and regioselective functionalization of many 
pyridine systems.90 However, probably the alkyllithium-promoted bromo-lithium exchange has 
been the most frequently employed methodology when 2-lithiated pyridines have been required 
for synthetic purposes. Thus, 2-lithiopyridine, obtained by treatment of 2-bromopyridine with n–
butyllithium, has been used in addition reactions to ketones,91 nitriles,92 amides93 and the ring-
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opening of sulfamates.94 Other substituted 2-pyridyllithium reagents have been obtained 
similarly and used recently in addition reactions to aldehydes,95 Weinreb amides,96 DMF,97 and 
acyl chlorides, as in the reaction of the organolithium 30, prepared from 2-bromopyridine 29 by 
the typical exchange procedure, with pivaloyl chloride (Scheme 10).98 The so-obtained ketone 31 
is an intermediate in the synthesis of a chiral 2,2’-bipyridine oxide catalyst for enantioselective 
















Examples of the generation of 2-lithiopyridines by iodo-lithium exchange in formylation 
reactions has been also reported.99 In addition, the halogen-lithium exchange has been used in the 
2-metalation of quinoline derivatives,100 and in the intramolecular cyclization of 2-pyridyl- and 
2-quinolidyllithium reagents such as 33, generated from the corresponding bromoquinoline 32, 




















Examples of the use of 3-pyridyllithium reagents (obtained by halogen-lithium exchange) 
can be found in the iodination of bromopyridines,102 in the addition to triphenylacetaldehyde (for 
the synthesis of chiral pyridine catalysts103), or to a conjugated dienic aldehyde (in a total 
synthesis of the kinase inhibitor pyridovericin104). The n-butyllithium-promoted bromo-lithium 
exchange has also been used in the generation of 3,5-dilithiopyridine, which has been employed 
in the addition to aromatic aldehydes for the synthesis of carbaporphyrinoids containing a 
pyridine moiety.105 Interestingly, a selectivity has been shown in the tert-butyllithium-mediated 
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metalation of 3-bromopyridines, the addition order of substrate and metalating agent being 
crucial for lithiation at C-3 by bromo-lithium exchange, or to C-4 by a DoM process.106
The DoM reaction applied to the generation of 3-pyridyllithium species has been carried out 
with tert-butyllithium in the case of 4-methoxypyridine,107 although the use of lithium amides is 
more frequent. Thus, 3-lithiated pyridines obtained using LDA as lithiation agent have found 
recent application in the 3-iodination of 2-fluoropyridine for the preparation of scaffolds for 
peptidomimetics,108 and also in the iodination of 2-chloro-4-cyanopyridine for the total synthesis 
of louisianin A.109 This lithiation agent has also been used for the 3-lithiation of 4-substituted 2-
chloropyridines such as 35 to generate a didehydropyridine (pyridyne) 37 by elimination of 
lithium chloride from lithiated species 36 (Scheme 12).110 The pyridyne 37 can be trapped with 


























3-Lithiated pyridines generated by the DoM procedure using LiTMP have been used for 
internal cyclization reactions to amide groups,111 and in the synthesis of heterocyclic quinones by 
metalation of pyridines and quinolines, in the presence of a remote carboxylate group.112 The 
same metalating agent has also been used for the synthesis of ortho-substituted cyanopyridines, 
an example being shown in Scheme 13, where the LiTMP-promoted metalation of 4-
cyanopyridine (39) gave the lithiated species 40 which reacts at 3-position with electrophiles, 
such as tetrabromomethane, to give the corresponding brominated compound 41.113  LiTMP has 
also been employed for the metalation of the pyridine moiety of pyridopyrimidin-4(3H)-ones and 
subsequent reaction with aldehydes.114 In addition, the above mentioned combination 
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Recent examples of the use of different 4-lithiopyridines, generated by DoM of 3-pyridyl 
pivaloamides using n-butyllithium, are an iodination reaction for the synthesis of 6-aza-L-
tryptophan116 and  4-alkoxycarbonylations in the preparation of pyridopyrimidin-ones.117 In the 
case of 3-bromopyridine, LDA has been used as metalating agent for the generation of the 
corresponding brominated 4-pyridyllithium reagent, which has been employed in an addition 
reaction to acrolein in the synthesis of restricted nicotine analogues.118 An illustrative example of 
a DoM reaction for preparing a synthetically useful 4-pyridyllithium species is the one-pot 
synthesis shown in Scheme 14. Thus, 3-pyridyl carboxylic acid 42 was treated with n-
butyllithium to give the corresponding carboxylate anion 43, and further lithiation with LiTMP 
afforded the organolithium species 44. Subsequent reaction with acetone gave the dilithium salt 
45, with was transformed into a lactopyridone after acid treatment. Final N-methylation under 
basic conditions gave the pyridinone alkaloid cerpegin 46.119 2-Bromo-3-fluoroquinolines have 
been lithiated by DoM at C-4 for the preparation of the corresponding carboxylic acids,120 
whereas 4,6-disubstituted dihydropyridopyrazines have been obtained from the corresponding 
carboxaldehydes via lithiation directed by the α-amino alkoxide generated by mixing the starting 





























In the case of the DoM 4-lithiation of 3,5-dichloropyridine using n-butyllithium and LiTMP, 
a comparison study monitored by infrared spectroscopy has shown similar structures of both 
lithio derivatives, although total deuteration occurred in the n-butyllithium-created species, 
whereas only partial deuteration was observed when LiTMP was used.122 The bromo-lithium 
exchange has been performed for instance starting from 2,4-dibromoquinoline, which by 
treatment with n-butyllithium gave rise to the corresponding 4-lithiated species, useful for 
iodination and subsequent palladium-catalyzed cross-coupling reactions.123
Pyridin-2-yldiazines have been recently metalated employing the pyridine ring as a ortho-
directing group.124 For instance, the lithiation of 2-pydidyl pyrazine 47 with LiTMP gave rise to 
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the pyrazyllithium intermediate 48, which can be quenched with electrophiles such as p-

























In general, it is not very important whether a pyrimidyllithium species is obtained by 
halogen/lithium exchange or direct deprotonation, the stability of the intermediate rather than the 
method of generation being the critical issue. Thus, 5-pyrimidyllithium species are fairly stable 
when the metal is flanked by two electron-withdrawing substituents such as trifluoromethyl and 
chlorine or bromine, and can be generated by direct n-butyllithium-promoted metalation.125 
Another example of direct metalation on a pyrimidine ring is the LiTMP-promoted lithiation of 
4-iodopyrimidine 50 to give 5-pyrimidinyllithium species 51, which has been formylated to 
afford the aldehyde 52 in a synthesis of 14-azacamptothecin, a water-soluble topoisomerase I 
poison (Scheme 16).126 This lithiating agent has also been used for the DoM preparation of 5-
lithio-2,4-di-tert-butoxypyrimidine, a useful heteroaryllithium used in the synthesis of 
pseudouridines.127 However, there are examples of formation of 5-pyrimidyllithium reagents 
without close stabilizating groups, as in the case of the tert-butyllithium-promoted bromo-lithium 
exchange in 5-bromo-2-[(trimethylsilyl)ethynyl)]pyrimidine, although the lithiation had to be 
performed at –100 ºC.128 Recent examples of the application of 4-lithiopyrimidines, created by 
bromo-lithium exchange, can also be found, as in an addition to a chiral lactone in a synthesis of 























ISSN 1424-6376 Page 163 ©ARKAT-USA, Inc. 
Issue in Honor of Prof. Alain Krief ARKIVOC 2007 (x) 152-231 
2.1.3. Nonaromatic heterocycles 
Non-stabilized N-anisyl aziridinyllithium reagents have been obtained via sulfoxide-lithium 
exchange using tert-butyl lithium at low temperature (–100 ºC), reacting afterwards with 
different electrophiles.130 The tin-lithium exchange has also been used for creating lithiated 
aziridines, an application of them being an internal Michael addition reaction to a 3-carboxylated 
indole in a synthesis of aziridines-containing antitumor agents.131 When an α-stabilizing group is 
required for a direct deprotonation, the trifluoromethyl group has been found to be appropriate. 
Thus, N-tosyl and N-anisyl-protected optically active trifluoromethyl aziridines have been 
lithiated at low temperature (–102 ºC) using alkyllithiums, giving aziridine anions as synthetic 
precursors of α-amino-α-trifluoromethylated compounds.132 However, more recently, the direct 
regio- and stereoselective deprotonation of N-sulfonyl-protected terminal aziridines has been 
achieved, as exemplified in the LiTMP lithiation of the aziridine 53 to give the aziridinyllithium 























2-Methyleneaziridinyl anions have been produced by C-3 deprotonation of the parent 
aziridine using sec-butyllithium/TMEDA and reacted with electrophiles affording the 
corresponding substituted methyleneaziridines.134 The process can be performed 
diastereoselectively when the starting aziridine bears a (S)-α-methylbenzyl group on the nitrogen 
atom,135 as in the case of aziridinyllithium species 57, generated by deprotonation of the aziridine 
56, which reacted with an electrophile such as allyl bromide affording the diastereoselectively 
enriched compound 58 (Scheme 18).134 The direct lithiation of aziridines using sec-
butyllithium/TMEDA has been facilitated when the next carbon atom is occupied by an 
oxazolinyl group, which can also affect the stereoselectivity of the further reaction with 
electrophiles due to their complexating properties.136 In addition, the formation of an aziridine-
borane complex facilitates the α-metalation and the control of the stereochemistry,137 the process 
being also performed with enantiopure complexes.138 
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The synthesis and applications of stabilized oxiranyllithium reagents has been recently 
reviewed.139 Examples of synthetic applications of lithiated aryloxiranes are the asymmetric 
synthesis of cyclopropanes from the reaction of oxiranyllithiums and α,β-unsaturated Fischer 
carbene complexes,140 or the use of a oxazolidine ring for directing and fixing the 
stereoselectivity of the lithiation, as commented in the case of aziridinyllithium reagents (see 
above). A recent example of the latter methodology is the diastereoselective lithiation of 
enantiomerically pure oxazolidinyl-substituted arylepoxide 59 to generate the organolithium 
reagent 60 (Scheme 19).141 This chiral oxiranyllithium species reacts with nitrones such as 
compound 61 to give the 1,6-dioxa-4,7-diazaspiro[4.5]decane derivative 62, which after some 

































The discovery that N-Boc-pyrrolidine could be asymmetrically α-deprotonated using sec-
buthyllithium in the presence of an stoichiometric amount of (–)-sparteine represented a key 
development in chiral organolithium chemistry.142,143 The procedure has allowed the synthesis of 
a series of 2-substituted pyrrolidines with high enantioselectivity, as well as enantiomerically 
enriched 5-substituted imidazolidines,144 although in only one enantiomerically enriched form. A 
recent example of the application of the thus generated (R)-N-Boc-2-lithiopyrrolidine-(–)-
sparteine complex 63 is the boron trifluoride etherate-assisted ring opening of ethylene oxide to 
give the alcohol 64 (Scheme 20).145 However, recently it has been reported a new sparteine-like 
diamine that gives predominantly the opposite absolute configuration of the organolithium 
species, acting as a (+)-sparteine surrogate,146 being also applied to the lithiation of piperidine.147 
This diamine has been used in a total synthesis of (–)-kainic acid.148 Rationalization for this 
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asymmetric deprotonation has been proposed revealing that the A-ring of sparteine is crucial for 
achieving the enantioselectivity,149 experimental and computational studies being extended to 






















The usually high enantioselection achieved in the asymmetric deprotonation-electrophilic 
trapping when stoichiometric amounts of (–)-sparteine are used, drops down when 
substoichiometric amounts are employed. However, its has been discovered that a ligand 
exchange approach can be used using a substoichiometric amount of (–)-sparteine, or the former 
(+)-sparteine surrogate, and an stoichiometric amount of an achiral diamine.151  
In the asymmetric deprotonation of N-Boc-pyrrolidine, the enantiomeric ratios are reduced 
when the chiral organolithium species is allowed to warm to -40 ºC prior to quenching. Kinetic 
studies on unstabilized (alkyl group on nitrogen), chelated (methoxyethyl group on nitrogen) and 
dipole-stabilized and chelated (Boc group on nitrogen) lithiopyrrolidines have shown that the 
barrier to enantiomerization is in the range of 19-22 Kcal/mol at 0 ºC.152 The ability of this 
organolithium species to undergo racemization has prompted the study of the dynamic 
thermodynamic resolution of racemic N-Boc-2-lithiopyrrolidine (generated by tin-lithium 
exchange) in the presence of a chiral diamine ligand, the enantioselectivity arising from the 
faster reaction of the minor diastereomeric complex with the electrophile.153 The knowledge on 
2-lithiopyrrolidines has been completed with structural studies on aggregation and dynamic 
solvation effects using NMR spectroscopy.154   
(4,5-Dihydrofuran-2-yl)lithium (65) has been prepared by tert-butyllithium-promoted 
metalation of 2,3-dihydrofuran,155 and there are examples of its use in alkylation reactions. For 
instance, when reacting intermediate 65 with the iodide 66 compound 67 was obtained (Scheme 













ISSN 1424-6376 Page 166 ©ARKAT-USA, Inc. 
Issue in Honor of Prof. Alain Krief ARKIVOC 2007 (x) 152-231 
There are recent examples of the generation of synthetically useful racemic N-protected 2-
lithio-pyrrolidine and piperidine systems, as in the synthesis of the lupin alkaloid (±)-cytisine via 
lithiation of N-Boc-bispidine,158 or the selective lithiation of N-Boc-2-phenyl-piperidine and 
pyrrolidine, with n-butyllithium. For instance, intermediate 68 (Scheme 22). reacts with an 
electrophile such as enantiomerically pure bromide 69 giving rise to the 2,2-disubstituted 
piperidine 70 as a mixture of diastereomers, one of them acting as an orally active NK1 receptor 
antagonist.159 In addition, there are examples of the use of (1,2,3,4-tetrahydroisoquinolin-1-
yl)lithium reagents as nucleophiles, generated by treatment of the corresponding N-substituted 
tetrahydroisoquinolines with alkyllithiums,160 or by reductive cleavage of 1-alkoxy-substituted 
























The lithiated heterocyclic species 72, obtained upon metalation of N-Boc-protected 1,3-
oxazinane 71 with sec-butyllithium, has been quenched with trimethylsilyl chloride affording the 
silylated derivative 73 (Scheme 23), as part of a formal synthesis of the alkaloid (±)-
pancratine.162 Finally, 2-lithio-1,3-dithianes are very well known lithiated heterocycles in organic 
synthesis as formyl or acyl anion equivalents,163 recent examples of their synthetic use in the last 


























3. Group 2 Metalated Heterocycles 
 
3.1. Magnesium heterocycles 
 
The synthesis of heterocyclic organomagnesium reagents, especially for nitrogenated  derivatives 
or compounds bearing different functionalities, is frequently problematic since the insertion of 
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magnesium metal to heteroaryl halides is inhibited when electron-withdrawing groups are 
present in the ring. However, the halogen/magnesium exchange performed by treatment of 
hateroaryl bromides or iodides with alkyl Grignards has shown nowadays to be a very useful and 
frequent methodology for the preparation of many functionalized heteroaromatic 
organomagnesium reagents.1,4,165 These organometallics can react with electrophiles or be used 
in transition-metal catalyzed cross-coupling reactions (the so-called Kharasch or Kumada 
coupling).166   
  
3.1.1. Aromatic five-membered rings 
The usual metalating methodology with alkyl Grignards has been employed in the treatment of 
1- and 2-iodoindoles with methylmagnesium bromide for the preparation of the corresponding 1- 
and 2-indolylmanesium bromides, which have been diastereoselectively added to chiral 1-
acylpyridinium salts.167 Another example is the addition of a 1-carboxylated 2-
indolylmagnesium chloride, generated by treatment of the corresponding iodide with 
isopropylmagnesium chloride, to arylazotosylates.168
2-Furylmagnesium bromide, obtained from 2-furyllithium by a lithium/magnesium exchange 
using magnesium bromide, has been used as nucleophile in substitution reaction of allyl 
acetoxides169 and in addition reactions to the nucleus of chiral pyridinium salts.170 However, 
more sensitive [5-(ethoxycarbonyl)furan-2-yl]magnesium chloride (74) has been generated from 
the corresponding 2-iodofurane by the usual treatment with isopropylmagnesium chloride, and 
used in an iron-catalyzed coupling reaction to aroyl cyanide 75 at –20 ºC to give the ketone 76 
(Scheme 24).171 The former 2-furylmagnesium reagent 74 can be prepared similarly from the 
corresponding 2-iodofurane in 93% yield at 25 ºC when bis[2-(N,N-dimethylaminoethyl)] ether  
(77) is added during the bromo/magnesium exchange, only a 57% yield of 74 being obtained in 
the absence of this complexating agent.172  In addition,  the direct α-magnesiation of furan has 
been recently achieved using a sodium magnesiate, generating a disodium dimagnesium 
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2-Thienylmagnesium bromide can be prepared by the traditional halogen-metal exchange 
using magnesium turnings and used as nucleophile in addition reactions to a 
decahydroisoquinoline-derived aldehyde,174 to vinylogous acyl triflates175 or to lactones.176 This 
heteromagnesium reagent has also been used in the copper-catalyzed ring-opening of azabicyclic 
alkenes,177 as well as metalated counterpart in the cobalt-catalyzed cross-coupling with alkyl 
halides.178 In addition, 2-thienylmagnesium bromide and some alkylated derivatives have been 
frequently employed in the preparation of highly conjugated compounds with electrooptical 
properties by means of cross-coupling reactions  with haloarenes using palladium,179 or more 
frequently, nickel-catalysts.180 Scheme 25 shows some applications of these couplings involving 
2-thienylmagnesiums. When other functionalities are present, other metalation procedures are 
more convenient. Thus, the treatment of the dihalogenated thiophene 78 with 
isopropylmagnesium bromide gave place to a iodo-magnesium exchange generating the 
thienylmagnesium derivative 79, which after nickel(0)-promoted polymerization afforded 
poly(3-hexylthiophene) (80) with a very defined molecular weight and low polydispersity.181 
Other example is the nickel-catalyzed coupling of the thienyl Grignard reagent 82, prepared from 
2,3-dihydrothieno[3,4-b][1,4]dioxine (81) by lithium-magnesium transmetalation, with the aryl 
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3-Thienylmagnesium reagents have been prepared from the corresponding brominated 
derivatives by bromine-magnesium exchange using alkylmagnesium halides and used, for 
instance, in nickel-catalyzed cross-coupling reactions.183 This exchange reaction can also be 
performed using i-PrMgCl⋅LiCl, the lithium salt enhancing the reactivity of the created 
arylmagnesium by breaking the Grignard polymeric aggregates.184 This procedure has been 
applied to some heteroaryl bromides such as 3-thienyl bromide, the resulting organomagnesium 
being used in an addition reaction to benzaldehyde.184  
Thiazolylmagnesiums metalated at C-2 have been obtained by the usual bromine-magnesium 
exchange using alkyl Grignards, even regioselectively, as it can be seen in Scheme 26 where the 
2-thiazolylmagnesium bromide 86 is obtained from 2,4-dibromothiazole (85). This reagent has 
been used in an addition reaction to the chiral nitrile 87 affording, after reduction, the amine 88, 
a building block for the synthesis of thiazolyl peptides.185 The lithium-magnesium 
transmetalation can also be used for the generation of thiazolylmagnesiums, an example being 
the preparation of 2-methylthiazol-4-ylmagnesium bromide, useful in the preparation of a 























3.1.1. Aromatic six-membered rings 
Magnesiated pyridines are usually prepared by the reaction of the corresponding bromide or 
iodide with alkyl or aryl Grignard reagents, although the direct metalation using magnesium 
turnings at higher temperatures can also be employed when no other functionalities are present, 
as the case of the recent use of 3-pyridylmagnesium bromide, generated at 70 ºC, for the 
preparation of aromatase inhibitors.187 However, the first method is more convenient due to the 
milder conditions employed, an example being the formation 5-bromopyridyl-2-magnesium 
chloride (90)  from 5-bromo-2-iodopyridine (89) by iodine-magnesium exchange at 0 ºC, and its 
use as nucleophile in the reaction with the Weinreb amide 91  to give the ketone 92 (Scheme 
27).188 In addition, 3-pyridylmagnesium reagents have been obtained similarly and used also in 
reactions with Weinreb amides189 and in additions to azo compounds.190  
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The above mentioned use of lithium chloride to enhancing the reactivity of alkyl Grignards 
employed in metalation reactions has also been used for the generation of 2-magnesiated 
pyridines employed in addition reactions to aldehydes191a and ketones,191b as well as in the 
preparation of 3-pyridylmagnesium reagents.192 Moreover, functionalized picolines have been 
recently obtained by using a bromine-magnesium exchange at C-3 employing an 
organomagnesium reagent generated by mixing n-butyllithium and isopropylmagnesium chloride 
and a subsequent reaction with electrophiles.193 Furthermore, 2-, 3- and 4-bromoquinolines such 
as compound 93 can be converted into the corresponding lithium tri(quinolinyl)magnesates such 
as 94 when exposed to n-Bu3MgLi.194 This organomagnesium compound 94 can be quenched 
with electrophiles194b or can be used in metal-catalyzed coupling reactions with heteroaryl 
halides194 to afford functionalized quinolines, as is the case of the palladium-catalyzed coupling 
with 2-bromopyridine to give the quinoline 95 (Scheme 28).194a Related lithium magnesate 
reagents have allowed the o-metalation of fluoropyridines,194a chloropyridines195b and 3-
fluoroquinoline195a to give pyridyl-195 and 2-quinolinylmagnesates.195a Finally, iodinated 
thioenopyrimidines and purines have been also transformed into magnesates for addition 



















dba = dibutylideneacetone 
dppf = 1,1'-bis (diphenylphosphino)ferrocene  
Scheme 28 
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The recently developed highly soluble mixed magnesium/lithium amide derived from 
2,2,6,6-tetramethylpiperidine 97, which has high kinetic activity because of the presence on the 
lithium chloride salt (see above), has shown to be a quite efficient base for the regioselective 
generation of functionalized heteroaryl magnesium compounds.197 For example, treatment of 2-
chloropyrimidine (96) with this reagent 97 allowed the generation of the corresponding 4-
magnesiated derivative 98 at –55 ºC which adds to p-bromobenzaldehyde to give the alcohol 99 
(Scheme 29). When the isopropylmagnesium chloride/lithium chloride mixture was used, the 
bromo/magnesium exchange in 5-bromo-4-halogeno-2,6-dimethoxypyrimidines and also the 
successive one-pot bromo/magnesium exchange and difunctionalization on 4,5-dibromo-2,6-

























4. Group 3 Metalated Heterocycles 
 
4.1. Boron Heterocycles 
 
Heterocyclic boronic acid derivatives are generally prepared by reaction of the corresponding 
organolithium derivatives with a trialkylborate,1,4,199 although there are examples of catalytic 
borylation of heteroarenes using iridium200 and rhodium complexes.200,201 The formed 
organoboron derivatives are used mainly for palladium-catalyzed cross-coupling reactions (the 
so-called Suzuki-Miyaura reaction166).   
 
4.1.1. Aromatic five-membered rings 
N-Boc-protected pyrrole boronic acid 100, obtained by the typical borination of the directly 2-
lithiated species, has been recently employed in the palladium-catalyzed coupling reaction to the 
brominated pyrrole enamine 101  to give the bipyrrole aldehyde derivative 102, which is a 
precursor of polypyrrole natural products of the prodigiosin series (Scheme 30).202 Another 
member of this family of natural products has been obtained by palladium-catalyzed coupling of 
the boron derivative 100 with a pyrrolyl triflate.203 This pyrrole boronic acid compound has also 
been employed in other cross-coupling reactions,204 including progesterone receptor 
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modulators205 and  the total synthesis of ageladine A.206 When the boronic acid functionality in 
the protected pyrrole is desired at C-3, its preparation is achieved generally via a bromination-
lithiation-borination sequence, a recent example being the synthesis of a N-silyl-protected pyrrol-























As expected, indolylboronic acids can be prepared and behave similarly to pyrroles, being 
also mainly used in cross-coupling reactions. Thus, N-substituted indolyl-2-boronic acids are 
obtained from the corresponding indole by direct lithiation followed by treatment with 
trimethylborate and hydrolysis,208 examples of their use being a cross-coupling reaction driving 
to a indolocarbazole alkaloid.209  Indolyl-3-boronic acids can be obtained by the former 
bromation-lithiation-borination sequence, as shown in the generation of an indol-3-
yl(pinacolboronate), as Suzuki-Miyaura boronic acid counterpart in a total synthesis of the bis-
indole alkaloid (+)- and (–)-dragmacidin F.210 However, there are examples of preparation of 
indol-3-ylboronic acids using other methodologies, such as the mercury-boron exchange, as 
shown in Scheme 31, where the indolylboronic acid 104 is obtained after 3-mercuriation of the 
bromoindole 103, being employed for a double coupling to 2,5-dibromopyrazine giving 
compound 105 in a formal total synthesis of dragmacidin B, trans-dragmacidin C and cis and 
trans-dihydrohamacanthins A.211  The Suzuki-Miyaura coupling employing different 
nitrogenated five- and six-membered heteroaryl boronic acids has been efficiently performed 
very recently using Pd2(dba)2-PCy3 as catalytic system in the presence of potassium 
phosphate.212 
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Furylboronic acids were prepared similarly to pyrrole derivatives, recent examples of the use 
of fur-2-ylboronic acid in Suzuki-Miyaura cross-couplings being frequent.213 3-Furylboronic 
acids have also been used in this type of reaction, for instance, in the coupling to a 6-
chloropurine ribonucleoside in the search for compounds with anti-HCV or cytostatic activity.214 
In addition, benzofurylboronic acids behave similarly to their non-benzocondensated 
counterparts, some recent examples of their use in Suzuki-Miyaura couplings being the synthesis 
of a precursor of the antimalarial machaeriol B,215  sulfamide HIV-1 protease inhibitors,216 
antifungal dihydrofuranones,217 heteroarylated azolopyrimidines218 or compound 108 from the 
coupling of benzofuran-2-ylboronic acid (106) and the bromonaphthalene 107 (Scheme 32).219 













Thien-2-ylboronic acids, prepared by lithium-boron exchange have been used recently in 
different Suzuki-Miyaura processes, being coupled to benzyl bromides,220 aryl halides,221 vinyl 
halides,222 or chloropyrimidones.223 Among these applications, those involving the preparation of 
highly conjugated systems involving the thiophene moiety with optoelectronic properties are 
particularly interesting.224 An illustrative example is the use of the thiophene boronic acid 109 
(obtained by 2-lithiation of the corresponding 2,4-dibrominated derivative and further treatment 
ISSN 1424-6376 Page 174 ©ARKAT-USA, Inc. 
Issue in Honor of Prof. Alain Krief ARKIVOC 2007 (x) 152-231 
with tri-n-butylborate) in the coupling to 1-bromo-4-fluorobenzene to give the brominated 
derivative 110 (Scheme 33).225 This compound has been used, after lithiation and coupling to 
octafluorocyclopentene, in the synthesis of dithienylethenes with photochromic properties.225 In 
addition, benzo[b]thiophenylboronic acids have been cross-coupled with 2-brominated 
dehydrophenylalanines.226 Moreover, copper-catalyzed cross-coupling reactions between an 
alkynyliodonium salt and thien-2-ylboronic acid  has also been reported.227 Interestingly, 

















Pinacole-derived thien-2-ylboronate derivative 112 has been recently obtained by copper(I)-
catalyzed cross-coupling reaction of 2-iodothiophene (111) with pinacolborane (Scheme X).229 
This type of thienylboronates have also been prepared using palladium-catalysis,230 as well as by 
lithiation of the thiophene system and further reaction with 2-isopropoxy(pinacole)borane.231  
These heteroaromatic pinacolboranes have been used in cross-coupling processes,230,232 but also 
in the Petasis reaction between  boronates, aldehydes and primary and secondary amines, as 
illustrated in Scheme 34, where boronate 112, glyoxylic acid and benzylamine react to give the 



















Examples of the use of thien-3-ylboronic acid (114) in Suzuki-Miyaura coupling reactions 
are the synthesis of 2- and 5-thienylated pyrazinones from the corresponding chlorides,234 as well 
as the coupling to bromosulfonamide 115 to give compound 116 (Scheme 35), in the search of 
selective EP1 receptor antagonists.235 In addition, potassium 3-thiophenetrifluoroborate (117) (as 
well as their furane and pyridine analogues) have been prepared from the corresponding boronic 
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acid by reaction with KHF2, and  has been used in palladium-catalyzed coupling reactions with 
heteroaryl halides236 or triflates, as shown in the preparation of the heteroarylated anisole 118 

























3-Aryl-1-H-pyrazoles have been recently obtained from the corresponding pyrazolyl pinacol-
derived boronates by Suzuki-Miyaura coupling. Thus, silyl-protected boronate 120 has been 
prepared from the corresponding pyrazole 119 by successive lithiation, reaction with 
triisopropylborate and condensation with pinacol (Scheme 36).239 The obtained boronates can be 
cross-coupled with an aryl iodide or bromide such as phenyl iodide to give the coupled product 
121. In addition, isoxazoles substituted with a  pinacol-derived boronic esters at C-3 have been 
obtained by [3+2] cycloaddition involving nitrile oxides and alkynylboronates.240 Moreover, 3-
benzyloxyisothiazole has been transformed into a isothiazo-5-yl boronic ester, intended to cross-
coupling reactions, via direct lithiation using LDA followed by boronic ester formation and 
transesterification.241  However, the yield was very low, probably due to the limited stability of 
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4.1.2. Aromatic six-membered rings 
Boronated pyridines are prepared normally via the usual lithium or magnesium transmetalation, 
frequently achieved by halogen-metal exchange or the DoM methodology. Among boronated 
pyridines, reports on the preparation of 2-pyridylboron species are rather sparse.199 However, 2-
pyridylboronic acid has been prepared in 70% yield from the corresponding 2-bromopyridine 
through initial reaction with isopropylmagnesium chloride and the usual metal-boron 
exchange.242 However, the lithium-boron transmetalation has been used in the case of the 
preparation of halopyrid-2-ylboronic acids and esters for palladium-catalyzed cross-couplings,243 
whereas 2,2’-bipyridines have been metalated with pinacol-derived boronic acid esters using an 
iridium-catalyzed borylation.244  
More stable 2-pyridylboron species, also suitable for cross-coupling reactions, are 2-
pyridinedioxazaborocanes such as 123, which can be prepared by esterification of the 
corresponding boronic acid with N-substituted diethanolamines243 or by reaction of the lithium 
boronate intermediate 122 with N-phenyldiethanolamine (Scheme 37).245a This boronate 123 has 
been used in Suzuki-Miyaura reactions such as the coupling with 1-iodo-4-nitrobenzene to give 
the arylpyridine 124. An N-anchored diethanolamine has also been used in this process, the 
























3-Pyridylboron reagents have been employed more frequently than their 2-boronated 
counterparts in Suzuki-Miyaura cross-coupling reactions. Thus, examples of the use of 3-
pyridinboronic acids in the last years are common,246 as it is the case of 2-ethoxy-3-
pyridylboronic acid 126, obtained by a DoM reaction of 2-ethoxypyridine (125), which has been 
employed for the coupling reaction with heteroaryl bromides such as 5-bromo-2-
methoxypyrimidine (127), to give the corresponding coupled product 128 (Scheme 38).247 In 
addition, examples of the use 4-pyridylboronic acids for the preparation of 4,4’-bipyridyl 
systems can be recently found,248 as well as the use of N-alkyl-boronopyridinium salts as 
thermally stable and reusable amide condensation catalysts.249 Moreover,  2- and 3-
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pyridylboronic acids have shown an unusual behaviour in the above mentioned Petasis reaction, 

























Examples of the use of pinacol-derived 3-pyridylboronates in the Suzuki-Miyaura reaction 
have been recently reported.251 These pyridylboronates have also been used in copper-promoted 
C-N252 and C-O253 bond cross-coupling reactions, an example being shown in Scheme 39 for the 
coupling of the pyridine-derived dioxaborolane 129 with p-chlorophenol (130), to afford the 
oxybisarylated compound 131 in the search of building blocks in cholinergic medicinal 
chemistry.253 This reaction seems to depend strongly on the pKa of the hydroxy compound, the 
higher the value, the more efficient the coupling. There are also examples of the use of 3-





















Highly substituted pyridazines have been prepared by a sequence involving cycloaddition 
reactions of pinacol-derived alkynyl boronic esters with symmetrical tetrazines and subsequent 
cross-coupling reaction using the formed pyridazine boronic ester.255 An example of this 
methodology is the cycloaddition of the tetrazine 132 with the alkynylboronate 133 to give the 
boronic ester 134 after nitrogen extrusion (Scheme 40). Subsequent palladium-catalyzed cross-
coupling with phenyl iodide gave the pyridazine 135. When the pyridazine boronic ester is 
treated with hydrogen peroxide, an oxidation to the 1H-pyridazin-4-ones takes place.255 In 
addition, 5-pyrimidylboronic acid and 2-methoxy-5-pyrimidylboronic acid, prepared by the 
typical halogen-lithium-boron exchange process, has been used for the synthesis of 
heteroarylpyrimidine derivatives via Suzuki-Miyaura cross-coupling reactions.256 
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4.1.3. Nonaromatic heterocycles 
3-Boronic ester-substituted pyrrolidines have been prepared via 1,3-dipolar cycloaddition of 
azomethine ylides to alkenyl boronates.257 An example is shown in Scheme X, for the reaction of 
the vinylboronate 136 and N-benzylated glycine in the presence of formaldehyde, to give the 3-
boronic ester pyrrolidine 137 (Scheme 41). This type of pinacol-derived boronates can be  
converted into boronic acids by transesterification with phenylboronic acid, or can be oxidatively 

















5. Group 4 Metalated Heterocycles 
 
5.1. Silicon heterocycles 
 
Silylated heterocyclic systems are frequently prepared by reaction of the corresponding 
heterocyclic organolithiums with alkylhalosilanes.1,4 The introduction of a silylated group can be 
required for blocking determined ring positions towards further transformations, as well as for 
ipso-substitution reactions by electrophiles or for palladium-catalyzed cross-coupling reactions 
with organic halides (the so-called Hiyama coupling166).  
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5.1.1. Aromatic five-membered rings 
N-Boc-Protected 2-pyrrolyldimetylsilanols,258 as well as their indolyl,259 thienyl258 and furyl1 
analogues, have been obtained by 2-lithiation and trapping with dimethyldichlorosilane followed 
by hydrolysis, and have been used in palladium-catalyzed coupling reactions with aryl halides. 
An example of the use of this methodology is the coupling of the pyrrolylsilanol 138 with p-
iodoanisole, where the starting silanol is treated previously with sodium hydride generating the 
corresponding sodium silanolate, which is the real species that couples with the aryl halide to 
give compound 139 (Scheme 42).258 A palladium-catalysis has also been used in a Suzuki-
Miyaura cross-coupling reactions involving an in situ ipso-borodesilylation of a N-protected 2-
(trimethylsilyl)-1H-indole followed by coupling with aryl halides.260 In addition, examples of the 
incorporation of a trimethylsilyl group at the 2-position of an indole, for protecting that position 



















2-Silylfuran derivatives substituted at the 3- or 4-positions are appropriate precursors of the 
corresponding regioisomeric γ-hydroxybutenolides, because they can be regiospecifically 
oxidized with singlet oxygen, thus the silyl group directing the formation of the carbonyl group. 
Applications of this methodology to the synthesis of natural products in the last years are 
frequent,262 as illustrated in Scheme 43 for the McMurry coupling of two molecules of 2-
silylated furan 140 to give the alkene 141 followed by photooxygenation in the presence of the 
sensitizer Rose Bengal, affording a mixture of diastereomeric bis-hydroxy butenolides 142. 
Subsequent dehydration using silica gel gave the bis-spiroketal 143, which is the spirocyclic core 
of prunolides, metabolites of static marine invertebrates.263 In addition, 2-trialkylsilyl furanes 
have been used in pericyclic reactions driving to the antibiotic viridin264 and  the skeleton of the 
diterpene ingenane.265 Moreover, 3-silylated furans, obtained by halogen-lithium-silicon 
exchanges or by DoM-directed lithiation-silylation have been used in an  ipso-boroxine 
formation,266 and in a reductive benzylation in a total synthesis of secosyrin 1,267 respectively.      
 
ISSN 1424-6376 Page 180 ©ARKAT-USA, Inc. 



























Thiophene derivatives containing a silyl group at the 2-position have been used in the 
preparation of π-conjugated thiophene-derived compounds with possible applications for 
electronic devices.268 For instance, the dithienophosphole 144269 has been used for a platinum-
catalyzed hydrosilation reaction with diphenylacetylene affording the diphenylethylene-
substituted species 145, which shows blue light-emitting properties (Scheme 44).270 The 2-
lithiation-silylation with tetramethydisiloxane sequence (employed for the introduction of the 
dimethylsilyl group in the synthesis of the former compound 144) has also been used for the 
preparation of polymer supported 2-silylated thiophenes, as well as trialkylsilanes when using 
trialkylsilyl chlorides as electrophiles.271 Moreover, when 2,5-bis(trialkylsilyl)thiophenes are 
intended, the thionation of bis(acylsilanes) with hexamethyldisilathiane under cobalt(II) chloride 
is a feasible route,272 and 2-thienylsilanols can be prepared by oxidation  of the corresponding 
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Scheme 44 
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Although N-substituted 5-silylpyrazoles can be obtained by the usual lithium-silicon 
exchange, another method consisting of the reaction of silyl β-enaminones with alkyl and aryl 
hydrazines has been recently developed. Using this methodology, N-methyl-3-silylpyrazoles 
have also been obtained, their regioselectivity depending on the employed hydrazine, as all 
hydrazines except methylhydrazine led to the 5-silylated pyrazoles.274 In addition, 3-
trimethylsilylindazoles, which are in fact benzocondensed counterparts of the corresponding 
pyrazoles, can be prepared by [3+2] cycloaddition reaction of lithium trimethylsilyldiazomethane 
with benzynes.275 These silylated indazoles can be used as nucleophilic precursors in the 
cesium(I) fluoride-promoted addition to aldehydes affording 3-substituted indazoles, although 
variable amounts of desilylated indazole are also obtained.276 This process is illustrated in 
Scheme 45, where 3-trimethylsilylindazole (146) is mixed with benzaldehyde in the presence of 
cesium(I) fluoride, which act as a base. The formed silicon-stabilized carbanion 147 adds to the 
carbonyl group to give the silylated species 148, which suffers a Brook rearrangement to give the 
O-silyl intermediate 149 which affords the 3-substituted indazole 150.276 These 3-



































Imidazoles have been silylated at C-2 using the conventional lithium-silicon exchange, 
although it has been observed that 2-tert-butyldimethylsilylimidazole can be obtained by reaction 
of O-tert-butyldimethylsilylimidazolyl aminals with organolithium reagents through a retro-
[1,4]-Brook rearrangement.278 Usually, 2-silylimidazoles are used a subsequent lithiation at the 
3-position and further reaction with electrophiles such as aldehydes279 or tosyl azide.280 
Similarly, 2-silylated oxazoles281 and thiazoles282 have been used performing a 4-lithiation 
followed by reaction with electrophiles.281 Their preparation by the typical lithium-silicon 
exchange is straightforward, although 2-trimethylsilyloxazoles, as well as other 2-silylated 1,3-
azoles have also been prepared by reaction with trimethylsilylbromide in the presence of 
triethylamine.283 In addition, 2-methylthiazole can be trimethylsilylated at C-5 by lithium-silicon 
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exchange, the resulting 2-methyl-5-silylthiazole permitting therefore a subsequent lithiation at 
the 2-methyl substituent.284 Furthermore, 2-trimethylsilylbenzothiazol has been directly 2-
acylated after treatment with an acyl chloride,285 and a 2-nucleophilic position for addition 
reactions can also be created by treatment with a phosphazene base.286     
 
5.1.2. Aromatic six-membered rings 
Chloro-, fluoro- and methoxypyridyltrimethylsilanes have been explored recently for a room 
temperature access to arylic heterocycles by means of a palladium catalyzed Hiyama cross-
coupling reaction.287 The presence of the pyridine nitrogen α to the trimethylsilyl group was a 
requisite to achieve the cross-coupling, as illustrated in the palladium-catalyzed reaction of 2-
trimethylsilylchloropyridine 151 with p-iodoanisole in the presence of tetra-n-butylammonium 















The 2-pyridylsilyl group has shown to be an interesting removable directing group for 
organometallic reactions, specially when alkenyl(2-pyridyl)silanes are involved, a very recent 
review covering this topic.288 Examples of these uses are the copper-catalyzed allylation of 
carbonyl derivatives using allyl(2-pyridyl)silanes as the allyl source,289a and a regioselective 
Mizoroki-Heck reaction on vinyl(2-pyridyl)silane for the synthesis of triarylene-based extended 
π-systems.289b (2-Pyridyl)allyldimethylsilanes such as compound 153 have also been employed 
recently in palladium-catalyzed cross-coupling reactions with aryl iodides such phenyl iodide in 
the presence of silver(I) oxide as an activator, to give the corresponding 2-phenylpyridine (154) 
(Scheme 47).290 In this process the effect of the allyl substituent on silicon was crucial, vinyl or 
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A trialkylsilyl group in a pyridine ring can be used for rerouting nucleophilic substitution 
reactions on di-, tri- and tetra-halopyridines. Thus, 2,4-difluoro, 2,4,6-trifluoro and 2,3,4,6-
tetrafluoropyridine, as well as their chlorinated analogues, undergo nucleophilic substitution 
preferentially at the 4-position, whereas the halogen at the 6- or 2-position is displaced 
selectively if a trialkylsilyl group is introduced at C-3 or C-5, respectively.291 In addition, a silyl 
group on a pyridine ring can be employed for the generation of a nucleophilic species when 
treated with fluoride, as shown in an internal cyclization driving to the total synthesis of the 
alkaloid louisianin C.292 
There are also recent examples of the use of the ipso-substitution reaction, such as the ipso-
iodination, applied to 3-trimethylsilylpyridine derivatives, as in the case of the reaction of the 
silylated pyridine 155 with iodine to give the 3-iodopyridine 156, which is a key compound for 















Chiral 1-acylpyridinium salts, prepared by reaction of 4-methoxy-3-(triisopropylsilyl)-
pyridine with an enantiomerically pure chloroformate, has been used for the diastereomeric 
addition of zinc enolates at C-2 of the pyridinium cation, driving to intermediates in the total 
synthesis of (+)-cannabisativine294 and (+)-hyperaspine.295 Another chiral 1-acylpyridinium salt 
from a 3-methoxycarbonylated 4-silylpyridine has been used for the addition of functionalized 
Grignard derived cuprates in the preparation of 6-substituted nipecotic acid derivatives.296
  
5.1.3. Nonaromatic heterocycles 
Although silylated aziridines have been obtained by lithiation-silylation of the corresponding 
aziridines, other procedures have been developed more recently. Thus, silyl aziridines can be 
prepared by reaction of silyldibromomethylithiums with aromatic imines followed by in situ 
treatment of the bromo aziridine intermediate with Grignard reagents.297 In addition, 2-
phosphono-3-(trimethylsilyl)aziridines have been synthesized by the aziridination of 1-
phosphono-2-aza-1,3-dienes with (trimethylsilyl)diazomethane.298
Epoxysilanes,299,300 as well as epoxydisilanes300,301 can be prepared from oxiranylithiums (see 
Section 2.1.3), although when synthetically useful functionalized silylated epoxides are intended, 
probably the more convenient route is the epoxidation of vinyl silanes.302 Thus, this  
methodology has been used for the synthesis of epoxysilanes useful in α-lithiation reactions,303 
generation of vinyl siloxanes under basic conditions304 [which give a formyl group after 
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treatment with fluoride304c or palladium(0)304f] and also in ring-opening reactions using lithium 
diphenylphosphide,305 Grignards306 or hidrides.307 Silyl epoxides, preapared by epoxidation, have 
also been used in oxidation reactions to give aldehydes,308 and SN2’ reactions in the case of 
silylated vinyloxiranes.309 Trimethylsilylated epoxides bearing a three methylene-containing 
tethered hydroxy group have been used in boron trifluoride-promoted internal cyclizations 
driving to tetrahydropyrans.310 Interestingly, when this Lewis acid is used with the diepoxyde 
157, the 5-exo-ditetrahydrofuran 158 is obtained in a ladder polyether fashion, whereas the more 
interesting natural product-containing tetrahydropyrane dyad 159  is generated after treatment of 
compound 157 with cesium carbonate (Scheme 49).311 The boron-trifluoride epoxide 





























The trimethylsilyl group has been enantioselectively introduced at C-2 of N-Boc-pyrrolidine 
by direct lithiation using sec-butyllithium in the presence of sparteine or sparteine-like chiral 
diamines and further reaction with trimethylsilyl chloride.149-151 This silyl group in related N-
methoxycarbonylated pyrrolidines has been removed by electrochemical oxidation giving an N-
acyliminium cation, which suffers addition of an alkyl radical generated by reaction of alkyl 
halides and hexa-n-butylditin, affording alkylated pyrrolidines.313 In addition, silylated 
pyrazolines and indazolines have been regioselectively prepared from the corresponding 
pyrazolium and imidazolium salts, respectively, with silyllithium reagents.314  
Examples of the synthesis of 3-silylated tetrahydrofurans by cyclization of silyl alcohols can 
be found.315a In addition, treatment of cyclopropyl silyl ketones such as 160 with trimethylsilyl 
trifluoromethanesulfonate gave the corresponding 5-silyl-2,3-dihydrofuran 161. These type of 
compounds exhibited both reactivity of the vinylsilane and the cyclic enol ether in the reactions 
with electrophilic reagents such as N-bromosuccinimide (NBS), affording the 4-bromo-2,3-
dihydrofuran 163 through the intermediate 162, or the α-silylated γ-lactone 165 (through species 
164) when working under basic aqueous conditions (Scheme 50).54 The same dual behavior was 
observed in Heck-type reactions.315b  
ISSN 1424-6376 Page 185 ©ARKAT-USA, Inc. 
















    DMF/H2O/

















The disilylated 1,4-dihydropyridine 166, generated by reductive disilylation of (S)-nicotine 
after treatment with lithium powder and trimethylsilyl chloride, has allowed the addition of 
aldehydes in the presence of a catalytic amount of TBAF to give C-5 substituted nicotines.316 2-
Silylated 5,6-dihydro-4H-pyranes such as 167 have been obtained by ruthenium-catalyzed 
cycloisomerization of diynes containing one silyl alkyne and one propargyl alcohol, and have 
been elaborated to give tetrahydropyran-2-ones using aqueous basic hydrogen peroxide,  or 















5.2. Germanium heterocycles 
 
Tri(2-furyl)germane has found recent applications in the radical-mediated germyldesulfonylation 
of vinyl and (α-fluoro)vinyl sulfones. Upon oxidative treatment with basic hydrogen peroxide, 
the resulting vinyl germane underwent palladium-catalyzed cross-coupling reactions with aryl 
halides.318 In addition, a dichlorogermanium-based linker for the solid-phase iterative synthesis 
of oligothiophenes has been developed, the oligothiophene being finally dettached from the solid 
fase by ipso-degermylation using trifuoroacetic acid.319 A related soluble thienylgermanium 
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species 168 has been used for a Friedel-Crafts acyldegermylation process leading to 
acylthiophene 169 (Scheme 51).320
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5.3. Tin heterocycles 
 
Heterocyclic stannanes are mainly obtained by reaction of the corresponding lithiated species 
with halostannanes,1,4 being mainly used in palladium-catalyzed cross-coupling reactions (the so-
called Stille-Migita coupling166). 
 
5.3.1. Aromatic five-membered rings 
2-Stannylpyrroles, prepared by direct 2-lithiation of the corresponding N-protected heterocycles 
and reaction with a chlorostannane, have been employed recently for cross-coupling reactions 
with aryl halides in the synthesis of stilbenylpyrroles,321 calixpyrroles,322 pyrrole-based 
polymers,323 compounds against cocaine abuse324 and fluorescence indicators.325 An example of 
generation and use of this stannylated pyrroles is shown in Scheme 52, with the N-lithium-
2,2,6,6-tetramethylpiperidine-promoted lithiation of N-Boc-pyrrole, followed by stannylation to 
give 2-stannylpyrrole 170. Subsequent double Stille coupling with dibrominated azulene 171 
gave the bis(pyrrolyl)azulene 172, which, once deprotected, is an efficient luminescent probe for 
fluoride.326 When 3-stannylated pyrrole are desired, a halogen-lithium exchange is usually 
performed, a recent example being the preparation and use of a 3-trimethylstannylated N–
tosylated pyrrole in the generation of a stannylated Diels-Alder adduct  for a copper-promoted 
trimerization.327  
 
ISSN 1424-6376 Page 187 ©ARKAT-USA, Inc. 






















N-Substituted indoles behave similarly to pyrroles, and can be 2-stannylated by direct 
lithiation followed by stannylation, these tin derivatives being used in Stille cross-coupling 
reactions.328 However, examples of the preparation of 2-stannylated indoles by bromo-lithium-tin 
exchanges can be recently found, for instance, in the preparation of inhibitors of the viral NS5B 
polymerase using the Stille coupling.329 As in the pyrrole case, 3-stannylated indoles can be 
prepared by the halogen-lithium-tin procedure, as well as related 7- azaindoles, also employed in 
palladium-catalyzed cross coupling reactions.330 In addition, palladium-catalyzed stannylation of 
3-iodinated 5-azaindoles using hexamethylditin has been used for the synthesis of the 
corresponding organostannanes.331  
2-Stannylated furans are prepared generally by the usual direct lithiation-stannylation 
procedure, recent examples of their use in Stille cross-couplings being frequent.332 In addition, 
tributyl(furan-2-yl)stannane has been used in a carbonylative Stille coupling reaction for the 
construction of the core structure of manzamine A.333  However, when labile group-substituted 
furans are the starting materials, some protective strategies must be developed, as in the recent 
case of the stannylation of 3-methylfurfural (173). Thus, in situ protection of the aldehyde 173 as 
the lithio-hemiaminal adduct followed by deprotonation of the furan nucleus gave intermediate 
174 (Scheme 53). Lithium-tin exchange afforded the stannyl furfural 175, which has been 
coupled with the vinyl iodide 176 affording compound 177, an intermediate in the total synthesis 
of the gorgonian coral metabolite (±)-bipinnatin J.334 
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As expected, the synthesis of 3-stannylated furans is usually carried out by halogen-lithium-
tin exchange procedures and their main use is in the Stille coupling reaction, as it was recently 
reported in the preparation of a 12-acetoxyazadiranone analogue of a limonoid triterpene.335 
However, when the synthesis of 3,4-distannylated furan 180 is intended, an efficient procedure 
consisting of palladium-catalyzed addition of hexa-n-butylditin to the alkyne 178 to give 
compound 179, followed by iodoxybenzoic acid (IBX) oxidative cyclization, has been developed 
(Scheme 54).336 This distannylated furan 180 has been employed in a double Stille coupling with 
the iodoarylated derivative 181  to give the disubstituted furan 182, which is a precursor of a 
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Probably, the most frequently employed 5-membered tin heterocycles are 2-stannylated 
thiophenes, prepared as usually by lithiation and further stannylation. These compounds have 
been used profusely in the last years for Stille cross-coupling reactions in the preparation of 
many oligo- and polythiophenes,338 as well as for other highly conjugated thiophene-containing 
oligo- and polymers,339 many of them with potentially useful electronic and electrooptical 
properties. Other molecules with interesting optical properties have been prepared using 2-
stannylated thiophenes, such as the bithiophene 186, which is a fluorescent marker by in vivo 
optical imaging of amyloid aggregates in brain (Scheme 55).340 This compound is obtained by 
Stille coupling of the stannylated bithiophene 183 and the O-silylated iodophenol 184 giving 
compound 185. Formylation of 185, followed by Knoevenagel condensation with malononitrile 
and final desilylation gave the final product 186. In addition, ligands for the dopamine D3 
receptor,341  organic dyes,342  acene-thiophene molecules for transistor applications,343  
fluorescent Ca(II)-indicators,344 luminescent europium(III) chelates,345 as well as thienylated 
benzodiazepins346 and other heterocycles,347 have also been obtained recently by Stille coupling 
using 2-stannylated thiophenes. Finally, an example of a useful 3-stannylated thiophene is 
compound 187, which has been prepared from its brominated derivative by bromo-lithium 
exchange, and has been used in a cross-coupling reaction for the preparation of 14C-labeled 
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Trifluoromethylated  5-(tri-n-butylstannyl)pyrazole 189, has been obtained recently by 
reaction of the propynylstannane 188 with diazomethane (Scheme 56),349 other stannylated 
triazoles and isoxazoles,28 as well as a 4-fluorinated pyrazole,350 being prepared by related 
dipolar cycloaddition reactions. After N-methylation of pyrazole 189 and tin-lithium exchange 
followed by addition to benzaldehyde, compound 190 was obtained. Subsequent O-alkylation 
under phase-transfer conditions gave pyrazole 191, which is a trifluoromethylated analogue of  
the analgesic cizolirtine.351 In addition, recent examples of the use of N-protected 2-352 and 3-
stannylated imidazoles,353 obtained by conventional lithium-tin exchange, in Stille cross-




































Isoxazoles stannylated at C-4- and C-5 have been obtained via a [2+3] cycloaddition reaction 
between substituted chloro oximes and tri-n-butylethynyltin, and used in cross-coupling 
reactions for the preparation of antibacterial agents.354  When 2-oxazolylstannanes are intended, 
the direct lithiation-stannylation methodology is usually employed, a recent synthetic example 
being the use of 2-(tri-n-butylstannyl)oxazole (193) and the vinyl iodide 192 in a Stille reaction 
driving to the polyene derivative 194, an intermediate in the synthesis of the eastern portion of 
the mycobacteria metabolite ajudazol A (Scheme 57).355 When 4-stannylated oxazoles bearing 
labile groups are required, the palladium-catalyzed stannylation using appropriately 4-substituted  
oxazoles and bis(trimethyltin) is a feasible methodology, an application of these tin-heterocycles 
being reported in the total synthesis of (+)-phorboxazole A,356 and some phorboxazole C 
analogues.357  
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2-Stannylthiazoles, generated by direct lithiation-stannylation, have been employed in 
palladium-catalyzed cross-couplings, examples being the coupling to aryl iodides in the 
development of matrix metalloproteinase inhibitors,358 or to aryl triflates for the synthesis of 
canine COX-2-inhibitors.359 In addition, thiazoles stannylated at C-4 are usually obtained by 
sequential halogen-lithium-tin exchange, and have been used for instance in Stille couplings  for 
the synthesis of epothilone B analogues,360 as well as the total synthesis of the antifungal agents 
cystothiazoles A and B361 and the fermentation broth metabolite WS75624 B.362 In some cases, 
4-stannylthiazoles are prepared by palladium-catalyzed cross-coupling of the corresponding 
bromide using bis(trimethyltin), as in the synthesis of the heterocyclic core of the GE2270 
antibiotic, a Stille coupling being a key step.363 Finally, 5-stannylated thiazoles can be prepared 
by direct lithiation-stannylation if a substituent blocks the 2-position, an example of their use in a 
Stille coupling being reported in the design of artificial nucleobases for molecular recognition.364  
 
5.3.2. Aromatic six-membered rings 
Stannylpyridines, generally obtained by reaction of a pyridyllithium with a halostannane, have 
been employed almost exclusively in the palladium-catalyzed Stille coupling reaction. Thus, 2-
stannylated and 2,6-distannylated pyridines have been frequently cross-coupled with halogenated 
or tosylated pyridines in the synthesis of bi-365 and terpyridines366 compounds with interesting 
metal-complexating or electrooptical properties. Supramolecular self-assemblies,367 as well as 
receptors for monosaccharides368 have also been recently prepared via cross-coupling reactions 
involving 2-stannylpyridines. Moreover, natural products such as several lupine alkaloids369 and 
(–)-7-demethylpiericidin A1370 have been obtained using cross-coupling reactions involving 2-
stannylated pyridines. Scheme 58 shows the use of the 2-stannylpyridine 196 (prepared by direct 
lithiation and reaction with trimethyltin chloride) in the cross-coupling with the heteroaromatic 
thioether 195. The resulting compound 197 is a pyridinyl analogue of the gram-positive 
antibacterial boxazomycin C.371  
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3-(Trialkylstannyl)pyridines have been used in palladium-catalyzed Stille cross-coupling 
reactions, recent examples being the reaction with halogenated pyridines for the synthesis of 
metal-complexating molecular suprastructures372 or nicotinic ligands,373 as well as the coupling 
with a vinyl bromide in the total synthesis of the epiphytic marine bacterium strain metabolite 
ent-thallusin.374 There are also examples of ipso-substitution of 3-stannylpyridines using an 
electrophilic reagent such as the generated by radioactive iodide in the presence of an oxidant, 
affording radiolabelled 3-iodopyridines.375 In addition, a recent example of the synthetic use of a 
4-pyridylstannane is the generation of the stannylated chloropyridine 199 by lithium-tin 
exchange from the iodopyridine 198 (Scheme 59). This heteroaromatic tin derivative has been 
used as Stille metalated counterpart in the coupling  with the starting iodopyridine 198 giving 





















The 4-(trimethylstannyl)quinoline 201, obtained by iodo-lithium-tin exchange, has been used 
for a double Stille coupling with 1,8-dibromonaphthalene to give the highly constrained (4,4’-
diquinolyl)naphthalene 202, which has been employed as fluorosensor (Scheme 60),377 similar 
systems with other alkyl substituents being also prepared.378 Moreover, related 1,8-
diacrydylnaphthalenes have been obtained employing Stille couplings involving the 5-
stannylated acridine 203,379 as well as 1-380 and 2-substituted analogues.381 
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4-Stannylpyridazines can be obtained by [4+2] cycloaddition of 1,2,4,5-tetrazines with 
ethynyltributyltin followed by molecular nitrogen extrusion. These compounds have been 
employed, for instance, in Stille reactions affording GABAA α5 ligands, as well as in ipso-
iodination reactions.382 In addition, pyrimidinylstannanes have been prepared using the lithium-
tin exchange methodology, although 2-stannylated pyrimidine 205 can also be prepared by 
reaction of the corresponding chloropyrimidine 204 with (tri-n-butylstannyl)lithium (Scheme 
61). This organotin species can be employed as a source of the corresponding organolithium (see 
Section 2.1.3) in an addition reaction to N-Boc-4-piperidone affording the alcohol 206, a 





















However, most of the stannylated pyrimidines have been dedicated to Stille reactions, as it 
can be seen in the coupling of the 4-stannylpyrimidine 207 (Scheme 62). This organotin 
compound was obtained by palladium-catalyzed halogen-tin exchange employing 
hexamethylditin and cross-coupled with the brominated tricyclic compound 208 to give the 
corresponding derivative 209, which is related to variolin marine alkaloids.384 Similar 4-
stannylpyrimidines have been used in the total synthesis of variolin B385 and deoxyvariolin B.385b 
Moreover, 5-stannylated pyrimidines have been used in palladium-catalyzed couplings to give 
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iodoimidazole-containing nucleosides for new base pairing motifs,386 and also in the preparation 


























Pyrazines stannylated at C-2 have been obtained by a direct lithiation-stannylation sequence 
and used recently in cross-coupling reactions with aryl halides for the synthesis of liquid crystal 
diazines,388 or with aroyl chlorides in the preparation of pyrazine alkaloids.389 This type of 
heteroaryl stannanes have been also obtained by halogen-lithium-tin exchange, and dedicated to 
Stille reactions in the synthesis of cyclin-dependant kinase inhibitors,390 and also from 2-
chloropyrazines by reaction with (tri-n-butylstannyl)lithium in the synthesis of polynuclear 
polyaza heterocycles.391 In addition, 2-stannylpurines, generated by direct 2-lithiation followed 
by reaction with a trialkylstannyl chloride, have also been used in Stille reactions, for instance, in 
the synthesis of adenosine derivatives.392 2-Stannylated purines have been also employed in the 
ipso-iodination reaction, thus creating a template for further functionalization,393 as illustrates 
Scheme 63 for the iodination of the stannyl purine ring of nucleoside derivative 210 affording 
the iodinated purine 211.394 Furthermore, the nitration of heteroaryltrimethyltins derived from 
pyridine, purine and even 1,3,5-triazine with nitrometane and dinitrogen tetroxide has been 
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5.3.3. Nonaromatic heterocycles 
Differently O-substituted cis-stannyl aziridines, such as 212, have been prepared by addition of 
(tri-n-butylstannyl)lithium to α-aminated aldehydes, followed by intramolecular cyclization of 
the resulting aminoalcohol. These stannylated systems have been used as reagents for the 
generation of the corresponding aziridinyllithium species after treatment with methyllithium.396 
Stannylated epoxides such as the enantiomerically enriched derivative 213 (79% ee) have been 
obtained by (–)-sparteine-induced enantioselective α-deprotonation of the corresponding achiral 
epoxides (see Section 2.1.3) followed by reaction with tri-n-butylstannyl chloride having been 
also used for the generation of the corresponding oxiranyllithiums.397 Terminal epoxides can also 










N-Boc-Protected 2-(tri-n-butylstannyl)pyrrolidine has been obtained by α-lithiation followed 
by reaction with tri-n-butylstannyl chloride, a procedure which can be rendered enantioselective 
if (–)-sparteine is added (see Section 2.1.3) thus driving to the synthesis of the (S)- stannylated 
enantiomer, as confirmed recently by anomalous dispersion X-ray analysis.399 In addition, 
enantiopure N-methyl-2-(tri-n-butylstannyl)pyrrolidine and its piperidine analogue have been 
prepared by a chiral trans-cumylcyclohexanol-induced stereoselective addition of (tri-n-
butylstannyl)lithium to an N-acylpyrrolidinium or piperidinium ion.400 However, racemic N-
alkylated  2-(tri-n-butylstannyl)pyrrolidines have been transformed into enantiomerically 
enriched 2-substituted pyrrolidines via dynamic resolution of the corresponding 2-
lithiopyrrolidine generated by tin-lithium transmetalation in the presence of (–)-sparteine and 
subsequent quenching with electrophiles (see Section 2.1.3). Furthermore, N-methyl-2-(tri-n-
butylstannyl)pirimidines have been studied in solution using NMR techniques showing distortion 
of the equatorial conformer to a half chair in some cases, something that could influence tin-
lithium transmetalation reactions.401  
5-Stannylated  N-Boc-protected 2,3-dihydro-1H-pyrrole 214 has been recently obtained by 
direct lithiation-stannylation of the corresponding N-Boc-pyrroline, and has been used in a Stille 
cross-coupling reaction with the vinyl triflate 215 to give the trienecarbarbamate 216. This 
compound has been heated to effect an electrocyclic ring closure and oxidized in situ with 
manganese(IV) oxide to give the marine sponge metabolite (±)-cis-trikentrin A (217) after Boc-
deprotection and aromatization (Scheme 64).402 Starting from a related stannylated pyrroline, 
(±)-cis-trikentrin B has been obtained.402
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Tetrahydrofurans stannylated at C-2, such as compound 218, have been employed for a 
cerium ammonium nitrate (CAN)-mediated oxidative acetal forming reaction through capture of 
the oxonium ion intermediate 219, thus driving to furo[2,3-b]pyrans such as the bicycle 220 
(Scheme 65).403 In addition, 5-tri-n-butylstannylated 2,3-dihydrofuran, prepared by stannylation 
of the corresponding dihydrofuryllithium, has been attempted in a palladium-catalyzed coupling 
with benzoyl chloride, although serious problems arising in the final separation of the 
benzoylated product from the resulting tri-n-butylstannyl chloride occurred.404 Moreover, 3-and 
4-stannylated furan-2(5H)-ones have been used for introducing the furanone moiety by means of 
the Stille reactions, examples involving furan-2-ones stannylated at C-3,405 C-4,406 or both 




















Tetrahydropyrans have been recently stannylated at the anomeric position by a reductive 
lithiation of the corresponding phenylthio acetals followed by a subsequent reaction with a 
trialkylstannyl chloride, the obtained 2-stannylated systems being used for tin-lithium 
transmetalation in an approach to the central core of amphidinol 3.408  However, a direct 
lithiation followed by a reaction with trialkylstannyl halides has been employed when the 
preparation of (5,6-dihydro-4H-pyran-2-yl)trialkylstannane is intended. An example can be seen 
in the synthesis of the stannylated glycal 221, which has been employed for a Stille cross-
coupling reaction with α-iodostyrene affording compound 222 (Scheme 66), an intermediate in 
the synthesis of the branched C-glycoside substructure of pluramycin antibiotic altromycin B.409 
Other 6-stannylated 3,4-dihydro-2H-pyrans have also been used recently in Stille couplings, as in 
the total synthesis of the neurotoxin azaspirazid-1410 or in the synthesis of spiroketals.411 These 
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organotin derivatives have also been employed as a source of organolithiums in a total synthesis 





















6. Group 5 Metalated Heterocycles 
 
6.1. Selenium heterocycles 
 
Selanylated heteroaromatic compounds are tipycally prepared from their organolithium 
counterparts by reaction with a selenylating agent. However, procedures such as the 
phenylselenenyl chloride-induced electrophilic cyclization of 2-alkynylated enones or 2-
alkynylated anisoles, have also been employed for the synthesis of 3-selanylated furans414 or 
benzo[b]furans,415 respectively.  In the case of selanylated pyridines, another synthetic method is 
the use of selenoates in a substitution reaction starting from halopyridines.416 Procedures such as 
the copper(I)-catalyzed arylselanylation of pyridyl bromides using tri-n-butyltin aryl selenides 
have also been applied.417
Selanylated tetrahydrofurans have been employed mainly in carbohydrate synthesis an can be 
obtained by addition of a selanylating agent to a 2,3-dihydrofuran, something that has been 
achieved photochemically,418 of via a selenonium cation.419 However, the most frequently 
employed selanylated systems in carbohydrate chemistry are α-selanylated tetrahydro-2H-
pyrans. Thus, these selenoglycosides have found many applications in this field as effective and 
stable glycosyl donors. They can be obtained by reaction of acetylated sugars with phenylselenol 
(obtained by reduction of diphenyldiselenide) and have been employed in elimination reactions 
to give 3,4-dihydro-2H-pyrans,420 or attached to diol linkers.421 Selenoglycosides have also been 
obtained from their corresponding glycosyl bromides by substitution reactions using 
selenoates,422 selenocarboxylic acids423 or their salts.424 and. An example of this latter 
methodology is the reaction of the glycosyl bromide 223 with  potassium p-
methylselenobenzoate (224) to give the β-selenoglycoside 225, which can react with an 
electrophile such as iodide 226, in the presence of an amine and cessium carbonate, to give the 
selenoglycosyl serine derivative 227 through an anomeric selenoate anion (Scheme 67).424a  
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Glycosyl bromides have also been used in the preparation of selenoglycosides after reaction 
with bis(phenylselanyl)zinc425 or after indium(I)-mediated cleavage of diselenides and further 
susbtitution reaction.426 In addition, the azidophenylselenylation of glycals has also been used for 
the synthesis of selenoglycosides,427 as well as the ring opening of epoxides with 
phenylselanol.428  
A recent synthetic application of one of these selanylated systems is the treatment of the 
selenoglycoside 228 with allyldimethylchlorosilane to give the 6-O-allylsilyl ether 229. Radical-
mediated cyclization of this compound gave the product 230, which was ring-opened via 
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β-Organoselenium-substituted butenolides have been obtaines from 2,3-allenoates and 
phenylselenenyl chloride, the presence of water being crucial for this electrophilic cyclization.430 
A particular example of this methodology is shown in the cyclization of the ethyl allenoate 232 
















6.2. Tellurium heterocycles 
 
Heteroaryl tellurides are usually prepared from the corresponding heteroaryllithium reagents 
after reaction with elemental tellurium an subsequent reaction with an alkyl halide,431 although a 
method consisting of microwave-assisted copper-catalyzed coupling of diaryl dichalcogenides 
and aryl halides has been recently developed.432 These tellurides have been found as suitable 
counterparts for some palladium-catalyzed cross-coupling reactions.433 An example is 2-(n-
butyltelluro)furan 234, obtained from furan following the usual method, which has been 
employed in a Suzuki-Miyaura cross-coupling reaction with potassium phenyltrifluoroborate, 
affording 2-phenylfuran (235) (Scheme 70).434 Similarly 2-tellurothiophene and 3-telluropyridine 
derivatives have also been used in this reaction.434 The process has also been performed using E-
















Symmetrical and unsymmetrical 2- and 3-pyridyltellurium compounds have been obtained 
from the corresponding pyridylmagnesium chlorides after treatment with elemental tellurium, 
dimerization achieved upon aerial oxidation.436 Other tellurium-substituted heterocycles have 
been obtained by a SNAr reaction using sodium arenetellurate ions, generated in situ by the 
reduction of diarylditelluride with sodium borohydride, as it is the case of the triazine 236, 
prepared by this method from 2,4,6-trichloro-1,3,5-triazine.437 In addition, β-
organotellurobutenolides, such as compound 237, have been prepared  by electrophilic 
tellurolactonization of α-allenoic acids, and have been used in both substitution reaction with 
cuprates or in palladium-catalyzed Sonogashira cross-coupling reactions.438
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[Ar = 4-FC6H4]  
 
 
7. Transition Metal-Substituted Heterocycles 
 
7.1. Titanium heterocycles 
 
Heteroaryltitanium reagents are usually prepared by lithium-titanium exchange, examples of 
their synthetic applications being rather limited in spite of their good reactivity and selectivity. A 
recent example of their use is the (silyloxyfuranyl)titanium reagent 238, generated by bromo-
lithium exchange from the corresponding silylated bromofuran followed by reaction with  
triisopropoxytitanium(IV) chloride. Addition reaction to the aldehyde 239 afforded the 
corresponding alcohol 240 mainly with a (R) stereochemistry at the newly created stereocenter 
(Scheme 71).439 Interestingly, an opposite stereoselection was achieved when the addition 
reaction was performed with the lithiated silyloxyfuran analogue. The alcohol X was used as an 
intermedite in the total synthesis of the antitumor diterpenoid (+)-zerumin B. The same 
organotitanium reagent X has also been used in other addition to a chiral aldehyde in the total 
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7.2. Copper heterocycles 
 
Heteroaryl copper reagents are usually obtained from the corresponding organolithium reagents 
(2 equivalents) by reaction with a copper(I) salt.1,4 However, other transmetalation procedures 
have been used, as in the case of furylcopper reagent 241 which has been prepared by mixing 2-
lithiofuran and magnesium(II) bromide followed by transmetalation with the complex copper(I) 
bromide-dimethylsulfide. The high order thiophene-derived cuprate 242 has been prepared by 
transmetalation of (benzyloxymethyl)tri-n-butylstannane with n-butyllithium and addition of the 
Lipshutz reagent (2-thienyl)Cu(CN)Li. Both reagents have been used in addition reactions of 2-









The former mixed high-order cyanocuprates of the type R(2-thienyl)Cu(CN)Li2, obtained as 
above from organolithium reagents, which bear non-transferable 2-thienyl ligand are very 
reactive and have shown high thermal stability and selectivity, being therefore used frequently as 
nucleophiles. Thus, these reagents have been employed recently, for instance, in Michael 
addition reactions,442 an example being the transfer of a butadienyl moiety to the unsaturated 
aldehyde 244 by means of the organocuprate 243 to give mainly the cis-product 245 (Scheme 
72).442e The ring-opening of aziridines443 and epoxides,444 as well as SN2’ reactions,445 have also 











The N-substituted 4,5-diiodoimidazole 246 has been regioselectively transformed into the 5-
cuprated imidazole 247 after reaction with (PhMe2CCH2)2CuLi. These organocopper reagents 
reacted with electrophiles such as allyl bromide to give the corresponding 5-functionalized 
imidazole 248 (Scheme 73).446 Examples of high order 5-oxazolyl cuprates in allylation and 
propargylation reactions,447 as well as 4-pyridinyl cuprates in allylation reactions448 have also 
been reported. 
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The scalemic 2-pyrrolidinylcuprate 249, generated via asymmetric lithiation of N-Boc-
pyrrolidine in the presence of (–)-sparteine (see Section 2.1.3) and further treatment with 
CuCN⋅2LiCl (1 equiv.), reacted with ω-functionalized vinyl halides, such as iodide 250, to give 
the corresponding enantiomerically enriched substituted pyrrolidine 251 (Scheme 74).449 When 
the starting scalemic lithiated species whas treated with 0.5 equiv. of  CuCN⋅2LiCl, the resulting 
cuprate of the type R2CuLi gave a slightly lower enantioselection (74% ee). This organocuprate-
based methodology has been applied to the synthesis of some alkaloids,449 such as the 
pyrrolizidine alkaloid (–)-pyrrolam A450 and the indolizidine alkaloid (+)-elaeokanine A.451 The 
N-Boc-protected 2-pyrrolidinyl-based scalemic cuprate of the type R2CuLi has also been used in 

















7.3. Zinc heterocycles 
 
Heterocyclic zinc species are usually prepared from their corresponding organolithium or 
organomagnesium counterparts by transmetalation with a zinc dihalide, the ratio of these 
reagents allowing to generate organozinc halides of diorganozincs. Organozincs are stable at 
higher temperatures than their precursors and frequently tolerate the presence of other 
functionalities.1,4 A frequent use of these zinc-derived reagents is in transition-metal-catalyzed 
cross-coupling reactions such as the palladium-catalyzed coupling with unsaturated halides (the 
so-called Negishi coupling166).   
 
7.3.1. Aromatic five-membered rings 
2-Indolylzinc chlorides have been used for a Negishi coupling with brominated 2-
azabicyclo[2.2.2]octenes in the preparation of analogues of the cocaine-intake reductor 
ibogaine.453 The nickel(II) chloride-diethyl phosphite system has been used as catalyst in cross-
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coupling reactions or organozincs, such as the coupling of (1-methylpyrrol-2-yl)zinc bromide 
with 3-bromopyridine.454  Iron  trichloride has also been used as catalyst in the cross-coupling 
reaction of some heteroarylzincs with alkyl halides, the reaction occurring probably through 
radical intermediates. Thus, N-methylated 2-indolylzinc derivative 253, bearing a non-
transferable (trimethylsilyl)methyl group, was generated upon treatment of the organozinc 
reagent 252 with [(trimethylsilyl)methyl]magnesium chloride, and reacted with 
cyclohexylchloride in the presence of catalytic amount of iron trichloride to give the 



















Di(furan-2-yl)zinc has been used as nucleophile in the ring opening of glycal epoxides to 
achieved the corresponding α-glycoside with high α-selectivity, similar results being obtained 
when using the furylzinc reagent generated by reaction of 2-furyllithium with zinc chloride.456 In 
addition, functionalized heteroaryl disulfides have been obtained by reaction of the 
corresponding functionalized zinc organometallics (such as 2-furylzinc and 3-indolylzinc 
bromides prepared by magnesium-zinc exchange) with sulfur monochloride.457
Thienylzinc compounds have been prepared under cobalt catalysis from thienyl chlorides and 
zinc metal,458  or from thienyl iodides using a zinc-copper couple in a microwave 
environment.459 This direct insertion of zinc into organic iodides and bromides has been 
performed very recently adding lithium chloride, a methodology similar to the acceleration of the 
bromo-magnesium exchange observed after addition of this salt (see Section 3.1.1).460 An 
example of the application of this methodology is the transformation of 2,5-diiodothiophene 
(255) into the thienylzinc-lithium chloride species 256 (after addition of 1.4 equivalents of zinc 
metal and lithium chloride) which afforded to ketone 257 after copper(I)-catalyzed acylation 
with benzoyl chloride (Scheme 76). Moreover, functionalized iodinated systems such as an 
acetylated 2-iodothiophene can be converted into diaryl zinc compounds after an iodo-zinc 
exchange using diisopropylzinc in the presence of a catalytic amount of nickel acetylacetonate to 
accelerate the otherwise slow halogen-zinc exchange. The obtained functionalized diorganozincs 
have been used for palladium-catalyzed Negishi couplings.461 
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As commented before, organozincs have been used mainly for palladium catalyzed cross-
coupling reactions, something that for thienylzinc reagents is specially more frequent. Thus, 
examples of the use of thiophene-derived organozincs  in a Negishi reaction for the preparation 
of 2,2’-dithienylated 1,1’-binaphthyls,462 2,5-diarylheteropentalenes,463 susbtituted azulenes,464 
analogues of tropane,465 carborane derivatives,466 2-pyrimidyl-5-amidothiophenes as inhibitors 
for AKT,467 4-thienylated quinolinones468 or multi[60]fullerenes with heterojunctions469 have 
been recently reported. In addition, thien-2-ylzinc iodide has been employed in a new rhodium-
catalyzed coupling reaction with (iodomethyl)trimethylsilane.470 
2-Thiazolylzinc reagents have also been used in Negishi cross-coupling reactions,471 as 
illustrated in Scheme 77 with the coupling of the organozinc reagent 258 with the 
dibromopyridine 259 to give compound 260, which is an intermediate in the synthesis of the 
























7.3.2. Aromatic Six-Membered Rings 
Pyridylzincs are usually prepared by the typical lithium-zinc transmetalation, and have been 
employed mostly in palladium-catalyzed Negishi cross-coupling reactions for introducing a 
pyridine nucleus. Thus, recent examples of the use of 2-pyridylzinc bromides and chlorides  as 
metalated counterpart in this coupling process are common,473 as in the case of the coupling of 2-
pyridylzinc bromide (261) with the chlorinated 2’-deoxyribosylpurine 262, affording compound 
263 in a synthesis of a purine-like nickel(II) base pair for DNA (Scheme 78).474a A similar 
process has been followed in the preparation of a related pirimidine-like system.474b 
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2-Fluorinated 4-pyridylzinc halides have also been used in palladium-catalyzed cross-
coupling reactions for the synthesis of pyridinyl-pyrimidines475 and analogues of the 
phenylamino-pyrimidine type protein kinase C inhibitor CGP 60474.476 In addition, dipyridin-2-
ylzinc has been used as nucleophile in a copper-catalyzed electrophilic amination using O-
acyl477a and O-benzoyl hydroxylamines477b has nitrogen sources. 
 
7.3.3. Nonaromatic heterocycles 
Thermally stable oxyranylzinc compounds have been obtained from optically pure 
trifluoromethyl oxiranes by a conventional low temperature lithiation, followed by metal 
exchange with zinc dichloride, being employed in Negishi couplings.132b This palladium-
catalyzed cross-coupling reaction has also been performed using pyran-2-ylzinc chloride (264), 
generated similarly by lithium-zinc transmetalation, and the racemic vinyl iodide 265 to give the 
alcohol 266 (Scheme 79). This compound can be cyclized under acid catalysis using 
camphorsulfonic acid (CSA) to spiroketal 267, a model for more complex systems present in a 





















7.4. Mercury heterocycles 
 
3-Mercuriated furans have recently been obtained regioselectively from propargylic 
dithioacetals, an example being shown in Scheme 80. Thus, treatment of the dithioacetal 268 
with n-butyllithium and benzaldehyde gave the allenyl species 269 which was allowed to react 
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with mercury(II) acetate to afford the corresponding organomercury derivative 271 through the 
dihydrofuran intermediate 270. This compound can be employed for the preparation of the 3-
iodofuran 272 upon reaction with iodine.479 This mercury-iodo exchange reaction has also been 
employed in a 2,5-bis(acetoxymercury)thiophene, obtained by reaction of the corresponding 
dilithiated compound with mercury(II) acetate, giving a 2,5-diiodothiophene useful in the solid-





































From the reading of this review, not totally comprehensive although extensive enough, it is easy 
to realize the large amount of synthetic work that has been carried out with of all kind of 
metalated heterocycles in only three and a half years. That shows the key role  that metalated 
heterocycles continue to play in synthetic organic chemistry. Starting from the quite frequent 
lithiated species, which are still the subject of many developments and studies, many other 
organometals with plenty of applications in transition-metal cross-coupling reactions for the 
preparation of nowadays interesting compounds have been obtained. Other metalated systems, 
such as organomagnesiums and organozincs have shown interesting developments in the very 
last years. It is sure that, as it has been until now, the use of metalated heterocycles will show a 
continuous flow of applications in the next years and will continue to be an indispensable 
synthetic tool in organic chemistry. 
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